Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

By Rebecca Robbins from NYT Health https://ift.tt/0U5OJ2v
via IFTTT
Health
Prices (Fares, Fees and Rates), Inventions and Patents, Drugs (Pharmaceuticals), Health Insurance and Managed Care, Law and Legislation, Regulation and Deregulation of Industry, State Legislatures, Autoimmune Diseases, Insurance, Generic Brands and Products, Antitrust Laws and Competition Issues, Enbrel (Drug)
New York Times
October 23, 2025 at 02:30PM